Gi‐Ae Kim

2.4k total citations · 1 hit paper
43 papers, 1.5k citations indexed

About

Gi‐Ae Kim is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Gi‐Ae Kim has authored 43 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 32 papers in Hepatology and 5 papers in Surgery. Recurrent topics in Gi‐Ae Kim's work include Liver Disease Diagnosis and Treatment (30 papers), Hepatitis B Virus Studies (20 papers) and Hepatitis C virus research (19 papers). Gi‐Ae Kim is often cited by papers focused on Liver Disease Diagnosis and Treatment (30 papers), Hepatitis B Virus Studies (20 papers) and Hepatitis C virus research (19 papers). Gi‐Ae Kim collaborates with scholars based in South Korea, United States and Nigeria. Gi‐Ae Kim's co-authors include Young‐Suk Lim, Seungbong Han, Han Chu Lee, Ju Hyun Shim, Kang Mo Kim, Jonggi Choi, Jihyun An, Yung Sang Lee, Danbi Lee and Young-Hwa Chung and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Gi‐Ae Kim

40 papers receiving 1.5k citations

Hit Papers

Critical appraisal of metabolic dysfunction-associated st... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
    2023 82 citations Gi‐Ae Kim, Joon Ho Moon et al. Clinical and Molecular Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gi‐Ae Kim South Korea 16 1.3k 1.1k 144 134 117 43 1.5k
Mi Na Kim South Korea 21 884 0.7× 756 0.7× 90 0.6× 89 0.7× 126 1.1× 75 1.2k
Shunichiro Fujiyama Japan 21 989 0.8× 887 0.8× 253 1.8× 129 1.0× 165 1.4× 87 1.3k
Sarah Temple United States 6 761 0.6× 652 0.6× 144 1.0× 113 0.8× 114 1.0× 16 953
Yoshitaka Takuma Japan 16 680 0.5× 699 0.6× 107 0.7× 101 0.8× 130 1.1× 31 1.0k
Yeonjung Ha South Korea 17 472 0.4× 518 0.5× 58 0.4× 126 0.9× 82 0.7× 50 848
Marco Biolato Italy 18 455 0.4× 420 0.4× 89 0.6× 58 0.4× 135 1.2× 50 965
Pietro Casarin Italy 14 769 0.6× 637 0.6× 165 1.1× 127 0.9× 317 2.7× 22 1.1k
Tasuku Hara Japan 20 713 0.6× 419 0.4× 322 2.2× 48 0.4× 120 1.0× 51 1.0k
Angeline Oi–Shan Lo Hong Kong 13 943 0.7× 730 0.6× 137 1.0× 30 0.2× 48 0.4× 22 1.2k
Takanori Hosokawa Japan 21 841 0.7× 921 0.8× 27 0.2× 93 0.7× 158 1.4× 33 1.2k

Countries citing papers authored by Gi‐Ae Kim

Since Specialization
Citations

This map shows the geographic impact of Gi‐Ae Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gi‐Ae Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gi‐Ae Kim more than expected).

Fields of papers citing papers by Gi‐Ae Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gi‐Ae Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gi‐Ae Kim. The network helps show where Gi‐Ae Kim may publish in the future.

Co-authorship network of co-authors of Gi‐Ae Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Gi‐Ae Kim. A scholar is included among the top collaborators of Gi‐Ae Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gi‐Ae Kim. Gi‐Ae Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jang, Suk‐Chan, Gi‐Ae Kim, Young‐Suk Lim, Hye‐Lin Kim, & Eui‐Kyung Lee. (2025). Association between everolimus combination therapy and cancer risk after liver transplantation: A nationwide population-based quasi-cohort study. American Journal of Transplantation. 25(6). 1285–1295. 1 indexed citations
2.
3.
4.
Kim, Gi‐Ae, Young‐Suk Lim, Seungbong Han, et al.. (2024). Viral Load–Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B. Annals of Internal Medicine. 177(10). 1308–1318. 5 indexed citations
5.
Kim, Gi‐Ae, Seung Won Choi, Seungbong Han, & Young‐Suk Lim. (2024). Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B. Clinical and Molecular Hepatology. 30(4). 793–806. 7 indexed citations
6.
7.
Choi, Won‐Mook, Gi‐Ae Kim, Jonggi Choi, et al.. (2023). Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B. Gut. 73(4). 649–658. 17 indexed citations
8.
Shim, Jae‐Jun, et al.. (2023). Comorbidities and the use of comedications among patients with chronic hepatitis C in Korea: A nationwide cross-sectional study. The Korean Journal of Internal Medicine. 38(3). 338–348. 1 indexed citations
9.
10.
Kim, Gi‐Ae, Joon Ho Moon, & Won Kim. (2023). Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity. Clinical and Molecular Hepatology. 29(4). 831–843. 82 indexed citations breakdown →
11.
Oh, Chi Hyuk, Jung‐Wook Kim, Gi‐Ae Kim, et al.. (2022). Benefits of Flavored Lactose-Free Milk for Korean Adults with Lactose Intolerance. Journal of Medicinal Food. 25(10). 1003–1010. 1 indexed citations
12.
Kim, Gi‐Ae, Chi Hyuk Oh, Jung‐Wook Kim, et al.. (2022). Association between non‐alcoholic fatty liver disease and the risk of dementia: A nationwide cohort study. Liver International. 42(5). 1027–1036. 31 indexed citations
13.
Lee, Jayoun, Gi‐Ae Kim, Hyo Jeong Kim, et al.. (2021). Tenofovir disoproxil fumarate on the risk of hepatocellular carcinoma in chronic hepatitis B patients with failure to preceding treatments: A nationwide cohort study. Journal of Viral Hepatitis. 28(8). 1150–1159. 1 indexed citations
14.
Yeo, Injoon, Gi‐Ae Kim, Hyunsoo Kim, et al.. (2020). Proteome Multimarker Panel With Multiple Reaction Monitoring–Mass Spectrometry for Early Detection of Hepatocellular Carcinoma. Hepatology Communications. 4(5). 753–768. 5 indexed citations
15.
Kim, Gi‐Ae, Seungbong Han, Gwang Hyeon Choi, Jonggi Choi, & Young‐Suk Lim. (2020). Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients. Alimentary Pharmacology & Therapeutics. 51(11). 1169–1179. 48 indexed citations
16.
Kim, Hye‐Lin, et al.. (2020). Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B. Gut. 70(11). 2172–2182. 26 indexed citations
17.
Choi, Gwang Hyeon, Gi‐Ae Kim, Jonggi Choi, Seungbong Han, & Young‐Suk Lim. (2019). High risk of clinical events in untreated HBeAg‐negative chronic hepatitis B patients with high viral load and no significant ALT elevation. Alimentary Pharmacology & Therapeutics. 50(2). 215–226. 64 indexed citations
18.
Lim, Young‐Suk, Seungbong Han, Jihyun An, et al.. (2015). Evaluation of Early-Stage Hepatocellular Carcinoma by Magnetic Resonance Imaging With Gadoxetic Acid Detects Additional Lesions and Increases Overall Survival. Gastroenterology. 148(7). 1371–1382. 100 indexed citations
19.
An, Jihyun, Young‐Suk Lim, Gi‐Ae Kim, et al.. (2014). Tenofovir Monotherapy in Chronic Hepatitis B Patients with Genotypic Resistance to Previous Antiviral Therapy. 46–46. 1 indexed citations
20.
Kim, Gi‐Ae, Young‐Suk Lim, Jihyun An, et al.. (2014). HBSAG Seroclearance after Nucleoside Analogue Therapy in Patients with Chronic Hepatitis B. 43–43. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mi Na Kim Breakdown of academic impact, for papers by Shunichiro Fujiyama Breakdown of academic impact, for papers by Sarah Temple Breakdown of academic impact, for papers by Yoshitaka Takuma Breakdown of academic impact, for papers by Yeonjung Ha Breakdown of academic impact, for papers by Marco Biolato Breakdown of academic impact, for papers by Pietro Casarin Breakdown of academic impact, for papers by Tasuku Hara Breakdown of academic impact, for papers by Angeline Oi–Shan Lo Breakdown of academic impact, for papers by Takanori Hosokawa
Rankless by CCL
2026